Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study "TIARA"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Documented atrial fibrillation or atrial flutter, paroxysmal or permanent
- Conventional indication for VKA treatment
- Signed informed consent

Exclusion Criteria

- Planned electro cardioversion
- Very high risk of TE (previous ischemic stroke or systemic TE, symptoms of heart failure or left ventricular dysfunction, mitral valve stenosis, hypertrophic cardiomyopathy)
- Indication for VKA treatment other than atrial fibrillation (e.g. mechanic valve prosthesis)
- Atrial fibrillation secondary to reversible diseases (e.g. thyrotoxicosis)
- Contraindication for treatment with VKA, aspirin, or clopidogrel